Some gain-of-function mutations on RBP4 promoter were reported to be associated with a higher risk of developing obesity or type 2 diabetes [15,16] while a non-coding mutation in RBP4 promoter is associated with dyslipidemia [17]. The gene discussed is RBP4; the disease is type 2 diabetes mellitus.